Please Wait.....

Report

Human Papillomavirus (HPV) Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (9-Valent HPV Vaccine, Quadrivalent HPV Vaccine, and Bivalent HPV Vaccine), Dosage (2 Dose and 3 Dose), Age (9 to 14 Years and 15 to 45 Years), Application (HPV-Attributable Cancer and Genital Warts), and Distribution Channel (Doctors Office, Community Health Clinics, School-Based Health Centers, Health Departments, Hospitals, and Others)

Market Report I 2022-06-16 I 277 Pages I The Insight Partners

Discounted by 30% to 2024-06-30

The global human papillomavirus (HPV) vaccine market was valued at US$ 4,273.84 million in 2022 and is projected to reach US$ 5,730.50 million by 2028; it is expected to grow at a CAGR of 5.0% from 2022 to 2028.

The growth of the human papillomavirus (HPV) vaccine market is mainly attributed to factors such as increase in prevalence of HPV associated diseases and rise in initiatives taken by global health organizations. However, the high cost of HPV vaccines hinders the overall market growth.

Healthcare organizations have developed and adopted several strategies to prevent and eliminate HPV infections. The World Health Assembly, in August 2020, adopted the global strategy for cervical cancer elimination. As per the strategy, to eliminate cervical cancer, all countries across the world must reach and maintain an incidence rate of below four per 100,000 women. To reduce the incidence rate of cervical cancer, countries should focus on vaccination, screening, and treatment of cervical cancer.
Further, in 2014, the American Cancer Society and the Centers for Disease Control and Prevention (CDC) established the National HPV Vaccination Roundtable dedicated to reducing the incidence of and mortality from HPV-associated cancer in the US alone. Additionally, the American Cancer Society's Mission: HPV Cancer Free is a public health initiative that aims at eliminating vaccine-preventable HPV cancers as a public health problem, starting with cervical cancer. Its goal is to reach an annual vaccination rate of 80% of 13-year-olds in the US by 2026.
In 2016, Gavi Board initiated an HPV vaccine program. That allows countries in their first year of the program to scale up and vaccinate girls between the age of 9 and 14 years. Through this new strategy, Gavi aimed to protect about 40 million girls from cervical cancer by 2020, preventing an estimated 900,000 deaths. 27 countries accepted the Gavi support and introduced the HPV vaccine in their national immunization program. Countries with the highest burden of cervical cancer globally, such as Malawi, the United Republic of Tanzania, Uganda, Zambia, and Zimbabwe, initiated the Gavi HPV vaccine program. All these initiatives are aiding the global HPV vaccines market substantially.
The COVID-19 pandemic is likely to have longer-term consequences on the HPV vaccine business. Many primary care clinics in the US have continued to operate at a reduced capacity to abide by social distancing measures and adopt stringent cleaning protocols. A reduction in in-person office visits limits opportunities for providers of vaccine to discuss and deliver vaccines. Barriers in transportation are likely to harm HPV vaccination; pharma and biotech companies traditionally find it difficult to market vaccines among the masses because of resistance received from parents and the absence of widespread awareness about school entry requirements that support other adolescent vaccines. The available evidence indicates that the COVID-19 pandemic has dramatically disrupted the delivery of HPV vaccines in 2020 and 2021. Early reports by CDC, suggest that ordering and billing dropped by >70% in March 2020. Furthermore, a 25-50% decrease in HPV vaccine orders continued in June 2020, in contrast to other early childhood-vaccine orders that resurged to near pre-pandemic levels. Although the revival of the HPV vaccine market is in progress, available data suggest that a short-term decline in HPV vaccination coverage will be substantial, and the demand for HPV vaccines will grow across North America in long term.
The COVID-19 pandemic placed health systems in Europe under unprecedented strain and disrupted the routine vaccination programs, which underscored the importance of resilient and sustainable immunization. The global crisis also hampered the HPV vaccination programs. Students in Europe were unable to attend school, uncertainties associated with the pandemic and subsequently affected operations in the education sector have led to delays in the administration of certain school-based vaccines. In Greece, the Hellenic Pediatric Society reported a 45 % fall in the number of pupils from the age group of 11-16 who received HPV vaccine doses in 2020. This urges the maintenance of routine immunization and recovery of coverage rates. The ambitious Beating Cancer Plan of Europe set a goal to vaccinate at least 90% of girls and significantly more boys by 2030 in school with HPV vaccine. With the subsequent decrease in COVID-19 cases in Europe, the HPV vaccination rate increased after June 2021 as summer and spring are the major seasons where people are affected by HPV.
The COVID-19 pandemic had significantly impacted the human papillomavirus (HPV) vaccine market. Human papillomavirus (HPV) vaccination programs have been severely impacted by the pandemic. Owing to the pandemic, 872 million students worldwide are unable to attend school due to the subsequent school closures, which have delayed delivery and administration of certain school-based vaccinations.

Based on type, the human papillomavirus (HPV) vaccine market is segmented into 9-valent HPV vaccine, quadrivalent HPV vaccine, and bivalent HPV vaccine. In 2022, the quadrivalent HPV vaccine segment holds the largest market share. However, the market for the 9-valent HPV vaccine segment is expected to witness rapid growth during 2022-2028. With HPV vaccination showing positive outcomes, the new 9-valent HPV vaccine was developed to increase protection against 5 more strains (i.e., HPV types 31, 33, 45, 52, and 58). The 9-valent HPV vaccine offers more protection against HPV than the quadrivalent HPV vaccine and is considered as a safer option.
Based on dosage, the human papillomavirus (HPV) vaccine market is segmented into 2 dose and 3 dose. In 2022, the 2 dose segment accounts for a larger market share. However the 3-dose segment is anticipated to register a higher CAGR in the market during the forecast period.
The global human papillomavirus (HPV) vaccine market, based on age, is segmented into 9 to 14 years and 15 to 45 years. The 9 to 14 years segment holds a larger share of the market in 2022, and the same segment is anticipated to register a higher CAGR during the forecast period.
In terms of application, the global human papillomavirus (HPV) vaccine market is segmented into HPV-attributable cancers and genital warts. The HPV-attributable cancers segment holds a larger share of the market in 2022, and the same segment is anticipated to register a higher CAGR during the forecast period.

On the basis of distribution channel, the global human papillomavirus (HPV) vaccine market is segmented into doctors office, community health clinics, school-based health centers, health departments, hospitals, and others. The hospitals segment held the largest share of the market in 2022, and the school based health centers segment is anticipated to register the highest CAGR in the market during the forecast period.
The World Health Organization (WHO), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), American Cancer Society and Gavi, The Vaccine Alliance, Australian Cervical Cancer Foundation's (ACCF) are a few of the major primary and secondary sources referred to while preparing the report of the global human papillomavirus (HPV) vaccine market.

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Human Papillomavirus (HPV) Vaccines Market - By Type
1.3.2 Global Human Papillomavirus (HPV) Vaccines Market - By Dosage
1.3.3 Global Human Papillomavirus (HPV) Vaccines Market - By Age
1.3.4 Global Human Papillomavirus (HPV) Vaccines Market - By Application
1.3.5 Global Human Papillomavirus (HPV) Vaccines Market - By Distribution Channel
1.3.6 Global Human Papillomavirus (HPV) Vaccines Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Human Papillomavirus (HPV) Vaccine Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Human Papillomavirus (HPV) Vaccine Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of HPV Associated Diseases
5.1.2 Initiatives Taken by Global Health Organizations
5.2 Market Restraints
5.2.1 High Cost of HPV Vaccines
5.3 Market Opportunities
5.3.1 Growing Number of HPV Awareness Programs
5.4 Future Trends
5.4.1 Advancements in HPV Diagnostics Tests
5.5 Impact Analysis
6. Human Papillomavirus (HPV) Vaccine Market- Global Analysis
6.1 Global Human Papillomavirus (HPV) Vaccine Market Revenue Forecast and Analysis
6.2 Global Human Papillomavirus (HPV) Vaccine Market, By Geography - Forecast and Analysis
6.3 Global Human Papillomavirus (HPV) Vaccine Market - Market Potential Analysis, By Region
6.4 Growth Strategy Analysis
6.5 Performance of Key Players
6.5.1 Merck & Co., In.
6.5.2 GSK
7. Global Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast To 2028- by Type
7.1 Overview
7.2 By Type: Market Revenue and Forecast Analysis (US$ Million)
7.3 9-valent HPV vaccine
7.3.1 Overview
7.3.2 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.4 Quadrivalent HPV vaccine
7.4.1 Overview
7.4.2 Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
7.5 Bivalent HPV Vaccine
7.5.1 Overview
7.5.2 Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)
8. Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 by Dosage
8.1 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)
8.2 2 Dose
8.2.1 Overview
8.2.2 2 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
8.3 3 Dose
8.3.1 Overview
8.3.2 3 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
9. Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 by Age
9.1 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)
9.2 9 to 14 Years
9.2.1 Overview
9.2.2 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
9.3 to 45 Years
9.3.1 Overview
9.3.2 to 45 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
10. Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 by Application
10.1 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)
10.2 HPV-attributable Cancer
10.2.1 Overview
10.2.2 HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
10.3 Genital Warts
10.3.1 Overview
10.3.2 Genital Warts: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
11. Global Human Papillomavirus (HPV) Vaccine Market Analysis and Forecast to 2028 - by End User
11.1 Overview
11.2 Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)
11.3 Doctor Office
11.3.1 Overview
11.3.2 Doctor Office Market Revenue and Forecast to 2028 (US$ Million)
11.4 Community Health Clinics
11.4.1 Overview
11.4.2 Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)
11.5 School-based Health Centers
11.5.1 Overview
11.5.2 School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)
11.6 Health Departments
11.6.1 Overview
11.6.2 Health Departments Market Revenue and Forecast to 2028 (US$ Million)
11.7 Hospitals
11.7.1 Overview
11.7.2 Hospitals Market Revenue and Forecast to 2028 (US$ Million)
11.8 Others
11.8.1 Overview
11.8.2 Others Market Revenue and Forecast to 2028 (US$ Million)
12. Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 Geographical Analysis
12.1 North America: Human Papillomavirus (HPV) Vaccine Market
12.1.1 Overview
12.1.2 North America: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.3 North America: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.1.4 North America: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.1.5 North America: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.1.6 North America: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.1.7 North America: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.1.8 North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
12.1.8.1 US: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.1 Overview
12.1.8.1.2 US: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.1.3 US: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.1.8.1.4 US: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.1.8.1.5 US: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.1.8.1.6 US: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.1.8.1.7 US: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.1.8.2 Canada: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.1 Overview
12.1.8.2.2 Canada: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.2.3 Canada: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.1.8.2.4 Canada: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.1.8.2.5 Canada: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.1.8.2.6 Canada: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.1.8.2.7 Canada: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.1.8.3 Mexico: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.1 Overview
12.1.8.3.2 Mexico: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.1.8.3.3 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.1.8.3.4 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.1.8.3.5 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.1.8.3.6 Mexico: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.1.8.3.7 Mexico: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.2 Europe: Human Papillomavirus (HPV) Vaccine Market
12.2.1 Overview
12.2.2 Europe: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.3 Europe: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.4 Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.5 Europe: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.6 Europe: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.7 Europe: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8 Europe: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
12.2.8.1 Germany: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.1 Germany: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.2 Germany: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.3 Germany: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.4 Germany: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.5 Germany: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.1.6 Germany: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8.2 France: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.1 France: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.2 France: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.3 France: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.4 France: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.5 France: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.2.6 France: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8.3 UK: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.1 UK: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.2 UK: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.3 UK: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.4 UK: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.5 UK: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.3.6 UK: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8.4 Italy: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.1 Italy: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.2 Italy: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.3 Italy: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.4 Italy: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.5 Italy: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.4.6 Italy: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8.5 Spain: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.1 Spain: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.2 Spain: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.3 Spain: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.4 Spain: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.5 Spain: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.5.6 Spain: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8.6 Russia: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.1 Russia: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.2 Russia: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.3 Russia: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.4 Russia: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.5 Russia: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.6.6 Russia: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8.7 Belarus: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.7.1 Belarus: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.7.2 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.7.3 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.7.4 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.7.5 Belarus: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.7.6 Belarus: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.2.8.8 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.8.1 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.2.8.8.2 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
12.2.8.8.3 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
12.2.8.8.4 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
12.2.8.8.5 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
12.2.8.8.6 Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
12.3 Asia Pacific Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028
12.3.1 Overview
12.3.2 Asia Pacific Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.3 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.4 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.5 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.6 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.7 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8 Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Country (2022 & 2028)
12.3.8.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.1 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.1.2 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.1.3 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.1.4 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.1.5 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.1.6 Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.1 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.2.2 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.2.3 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.2.4 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.2.5 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.2.6 China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.1 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.3.2 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.3.3 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.3.4 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.3.5 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.3.6 India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.1 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.4.2 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.4.3 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.4.4 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.4.5 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.4.6 South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.1 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.5.2 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.5.3 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.5.4 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.5.5 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.5.6 Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.6 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.1 New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.6.2 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.6.3 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.6.4 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.6.5 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.6.6 New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.7 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.7.1 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.7.2 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.7.3 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.7.4 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.7.5 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.7.6 Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.8 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.8.1 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.8.2 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.8.3 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.8.4 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.8.5 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.8.6 Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.9 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.9.1 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.9.2 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.9.3 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.9.4 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.9.5 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.9.6 Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.10 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.10.1 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.10.2 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.10.3 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.10.4 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.10.5 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.10.6 Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.11 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.11.1 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.11.2 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.11.3 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.11.4 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.11.5 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.11.6 Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.3.8.12 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
12.3.8.12.1 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
12.3.8.12.2 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
12.3.8.12.3 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
12.3.8.12.4 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
12.3.8.12.5 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
12.3.8.12.6 Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
12.4 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast To 2028
12.4.1 Overview
12.4.2 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.3 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.4 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.5 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.6 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.7 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.4.8 Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
12.4.8.1 UAE: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.4.8.1.1 Overview
12.4.8.1.2 UAE: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.8.1.3 UAE: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.8.1.4 UAE: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.8.1.5 UAE: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.8.1.6 UAE: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.8.1.7 UAE: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.4.8.2 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.4.8.2.1 Overview
12.4.8.2.2 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.8.2.3 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.8.2.4 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.8.2.5 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.8.2.6 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.8.2.7 Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.4.8.3 South Africa: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.4.8.3.1 Overview
12.4.8.3.2 South Africa: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.8.3.3 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.8.3.4 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.8.3.5 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.8.3.6 South Africa: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.8.3.7 South Africa: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.4.8.4 Iran: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.4.8.4.1 Overview
12.4.8.4.2 Iran: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.8.4.3 Iran: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.8.4.4 Iran: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.8.4.5 Iran: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.8.4.6 Iran: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.8.4.7 Iran: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.4.8.5 Turkey: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.4.8.5.1 Overview
12.4.8.5.2 Turkey: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.8.5.3 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.8.5.4 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.8.5.5 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.8.5.6 Turkey: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.8.5.7 Turkey: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.4.8.6 Kuwait: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.4.8.6.1 Overview
12.4.8.6.2 Kuwait: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.8.6.3 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.8.6.4 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.8.6.5 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.8.6.6 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.8.6.7 Kuwait: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)
12.4.8.7 Bahrain: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
12.4.8.7.1 Overview
12.4.8.7.2 Bahrain: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
12.4.8.7.3 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Type, 2019-2028 (US$ Million)
12.4.8.7.4 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Dosage, 2019-2028 (US$ Million)
12.4.8.7.5 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Age, 2019-2028 (US$ Million)
12.4.8.7.6 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Application, 2019-2028 (US$ Million)
12.4.8.7.7 Bahrain: Human Papillomavirus (HPV) Vaccine Market, by End User, 2019-2028 (US$ Million)

LIST OF TABLES
Table 1. North America Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Human Papillomavirus (HPV) Vaccine Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 6. US Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 7. US Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 8. US Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 9. US Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. US Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 25. Europe: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 26. Germany: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 30. Germany: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 31. France: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 32. France: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 33. France: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 34. France: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 35. France: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 36. UK: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 37. UK: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 38. UK: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 39. UK: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 40. UK: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 41. Italy: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 45. Italy: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 46. Spain: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 47. Spain: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 48. Spain: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 49. Spain: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 50. Spain: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 51. Russia: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 52. Russia: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 53. Russia: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 54. Russia: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 55. Russia: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 56. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 57. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 58. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 59. Belarus: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 60. Belarus: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 61. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 62. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 63. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 64. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 65. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 66. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 67. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 68. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 69. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 70. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 71. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 72. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 73. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 74. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 75. Japan: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 76. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 77. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 78. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 79. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 80. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 81. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 82. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 83. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 84. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 85. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 86. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 87. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 88. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 89. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 90. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 91. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 92. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 93. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 94. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 95. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 96. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 97. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 98. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 99. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 100. New Zealand : Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 101. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 102. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 103. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 104. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 105. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 106. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 107. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 108. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 109. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 110. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 111. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 112. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 113. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 114. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 115. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 116. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 117. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 118. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 119. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 120. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 121. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 122. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 123. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 124. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 125. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 126. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Type (US$ Million)
Table 127. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Dosage (US$ Million)
Table 128. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Age (US$ Million)
Table 129. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Application (US$ Million)
Table 130. Rest of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by End User (US$ Million)
Table 131. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 132. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 133. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 134. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Application- Revenue and Forecast to 2028 (US$ Million)
Table 135. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 136. UAE Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 137. UAE Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 138. UAE Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 139. UAE Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 140. UAE Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 141. Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 142. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 143. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 144. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 145. Saudi Arabia Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 146. South Africa: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 147. South Africa Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 148. South Africa Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 149. South Africa Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 150. South Africa Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 151. Iran: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 152. Iran Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 153. Iran Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 154. Iran Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 155. Iran Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 156. Turkey: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 157. Turkey Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 158. Turkey Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 159. Turkey Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 160. Turkey Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 161. Kuwait: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 162. Kuwait Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 163. Kuwait Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 164. Kuwait Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 165. Kuwait Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 166. Bahrain: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 167. Bahrain Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 168. Bahrain Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 169. Bahrain Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 170. Bahrain Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 171. Egypt: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 172. Egypt Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 173. Egypt Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 174. Egypt Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 175. Egypt Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 176. Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Type - Revenue and Forecast to 2028 (US$ Million)
Table 177. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Dosage- Revenue and Forecast to 2028 (US$ Million)
Table 178. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Age- Revenue and Forecast to 2028 (US$ Million)
Table 179. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 180. Rest of Middle East & Africa Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 181. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million).
Table 182. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 183. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 184. South & Central America: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 185. South & Central America: Human Papillomavirus (HPV) Vaccine Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 186. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 187. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 188. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 189. Argentina: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 190. Argentina: Human Papillomavirus (HPV) Vaccine Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 191. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 192. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 193. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 194. Brazil: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 195. Brazil: Human Papillomavirus (HPV) Vaccine Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 196. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 197. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 198. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 199. Chile: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 200. Chile: Human Papillomavirus (HPV) Vaccine Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 201. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 202. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 203. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 204. Guatemala: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 205. Guatemala: Human Papillomavirus (HPV) Vaccine Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 206. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 207. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 208. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 209. Peru: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 210. Peru: Human Papillomavirus (HPV) Vaccine Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 211. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 212. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 213. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 214. Colombia: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 215. Colombia: Human Papillomavirus (HPV) Vaccine Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 216. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Type (US$ Million)
Table 217. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Dosage (US$ Million)
Table 218. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Age (US$ Million)
Table 219. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 220. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 221. Recent Inorganic Growth Strategies in the HPV Vaccines Market
Table 222. Recent Organic Growth Strategies in the HPV Vaccines Market
Table 223. Glossary of Terms

LIST OF FIGURES
Figure 1. Human Papillomavirus (HPV) Vaccines Market Segmentation
Figure 2. Human Papillomavirus (HPV) Vaccines Market, By Region
Figure 3. Global Human Papillomavirus (HPV) Vaccine Market Overview
Figure 4. 9-Valent HPV Vaccine Segment Held Largest Share of Type Segment in Human Papillomavirus (HPV) Vaccines Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Human Papillomavirus (HPV) Vaccine Market, by Geography (US$ Million)
Figure 7. Global Human Papillomavirus (HPV) Vaccine Market - Leading Country Markets (US$ Million)
Figure 8. Global Human Papillomavirus (HPV) Vaccine Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Human Papillomavirus (HPV) Vaccines Market Impact Analysis of Driver and Restraints
Figure 16. Global Human Papillomavirus (HPV) Vaccine Market- Revenue Forecast and Analysis - 2022 - 2028
Figure 17. Global HPV Vaccines Market - By Geography Forecasts And Analysis - 2022- 2028
Figure 18. Global Human Papillomavirus (HPV) Vaccine Market - Market Potential Analysis, By Region
Figure 19. Global HPV Vaccines market - Growth Strategy Analysis
Figure 20. By Type: Market Analysis and Forecast 2022 and 2028 (%)
Figure 21. 9-valent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Quadrivalent HPV vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 23. Bivalent HPV Vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Dosage (2022 and 2028)
Figure 25. 2 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. 3 Dose: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Age (2022 and 2028)
Figure 28. 9 to 14 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. to 45 Years: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by Application (2022 and 2028)
Figure 31. HPV-attributable Cancer: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Genital Warts: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Human Papillomavirus (HPV) Vaccine Market Revenue Share, by End User (2022 and 2028)
Figure 34. Doctor Office Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Community Health Clinics Market Revenue and Forecast to 2028 (US$ Million)
Figure 36. School-based Health Centers Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Health Departments Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Hospitals Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Others Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Human Papillomavirus (HPV) Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
Figure 41. North America Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
Figure 43. US: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Canada: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Mexico: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Europe: Human Papillomavirus (HPV) Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
Figure 47. Europe: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Europe: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
Figure 49. Germany: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. France: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. UK: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 52. Italy: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 53. Spain: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Russia Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Belarus: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Rest of Europe: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 57. Asia Pacific Human Papillomavirus (HPV) Vaccines Market Overview, by Country (2022)
Figure 58. Asia Pacific Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 59. Asia Pacific: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028, by Country (2022 & 2028)
Figure 60. Japan Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 61. China: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 62. India: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Korea: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 64. Australia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 65. New Zealand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 66. Philippines: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 67. Thailand: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 68. Malaysia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 69. Singapore: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 70. Indonesia: Human Papillomavirus (HPV) Vaccines Market Revenue and Forecast to 2028 (US$ Million)
Figure 71. Rest Of Asia Pacific: Human Papillomavirus (HPV) Vaccines Market- Revenue and Forecast to 2028 (US$ Million)
Figure 72. Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Key Country - Revenue (2022) (US$ Million)
Figure 73. Middle East & Africa Human Papillomavirus (HPV) Vaccine Market Revenue and Forecast to 2028 (US$ Million)
Figure 74. Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market, by Country, 2022 & 2028 (%)
Figure 75. UAE: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 76. Saudi Arabia: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 77. South Africa: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 78. Iran: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 79. Turkey: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 80. Kuwait: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 81. Bahrain: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 82. Egypt: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 83. Rest of Middle East & Africa: Human Papillomavirus (HPV) Vaccine Market - Revenue and Forecast to 2028 (US$ Million)
Figure 84. South & Central America Human Papillomavirus (HPV) Vaccine Market Overview, by Country (2022)
Figure 85. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 86. South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028, By Country (%)
Figure 87. Argentina: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 88. Brazil: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 89. Chile: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 90. Guatemala: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 91. Peru: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 92. Colombia: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 93. Rest of South & Central America: Human Papillomavirus (HPV) Vaccine Market Revenue and Forecasts to 2028 (US$ Million)
Figure 94. Impact of COVID-19 Pandemic in North American Country Markets
Figure 95. Impact of COVID-19 Pandemic in European Country Markets
Figure 96. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 97. Impact of COVID-19 Pandemic on Middle East & African Countries
Figure 98. Impact of COVID-19 Pandemic on South & Central America Countries
Figure 99. Growth Strategies in the HPV Vaccines Market, 2021-2028

Not Sure / Need Reassuring
- Confirm Content
  - Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
    
    Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
    
    Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
    
    Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
- Sample Pages
  - With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
    
    It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
    
    To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Check for Alternatives
  - Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
    
    To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
Prices / Formats / Delivery
- Prices
  - All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
    
    Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Discounts
  - As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
    
    Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
    
    To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
- Available Currencies
  - Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
    
    Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
    
    To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
- Licenses
  - License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Global Site License
  - The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
    
    It is important to note that this may exclude Parent Companies or Subsidiaries.
    
    If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
- Formats
  - The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
    
    If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
- Delivery
  - Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
    
    Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
    
    If a delay in delivery is expected you will be informed about it immediately.
- Shipping Charges
  - As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
    
    If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
Ordering
- By Credit Card
  - We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
    
    Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
    
    For more information on PayU please visit: https://www.payu.pl/en/about-us
- By Money Transfer
  - If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
    
    With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
Security
- Website security
  - We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
    
    Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
- Credit Card Security
  - We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
    
    PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

Single User Price

$4550.00 $3185.00
Site Price

$6550.00 $4585.00
Enterprise Price

$8550.00 $5985.00
ADD TO BASKET
BUY NOW

Make order by PDF ASK A QUESTION

"I’ve taken over the overall responsibility for Market Intelligence at XXXX, and have heard good things about working with you."

"Nicholas’s exceptional communication skills combined with knowledge makes him a great asset to any organisation and clients he assists."

"Thank you again for your continued support and service mindset."

"I have been working with Nicholas since 2006 and to date have always been content."

"I cannot speak highly enough of Nicholas`s professionalism, information industry knowledge and enthusiasm."

"Nicholas is very good at following up on clients requirements and updating them on future interest areas."

"Nicholas`s natural skills make him successful in dealing with customers from dozens of different countries."

"As always, thank you very much for being so responsive!"

Please Wait.....

Report

Send us a message:

SORRY

Different report currency

Many thanks for completing the form, a member of our team will review and be in contact shortly.

Did not get the email?

We tried again, please check